<DOC>
	<DOC>NCT02897297</DOC>
	<brief_summary>All patients diagnosed or followed in Brest University Hospital for Philadelphia negative MPNs will be included in this observational study. MPNs recorded included: polycythemia vera (PV), essential Thrombocythemia (ET) and Primary Myelofibrosis (PMF). This is a not interventional study. Alive patients need to sign a non-opposition consent form. Patients will be followed until last news (death, change of reference centre...).</brief_summary>
	<brief_title>Myeloproliferative Neoplastic Diseases Observatory From Brest</brief_title>
	<detailed_description>In this retrospective and prospective study, clinical and biological data from diagnosis until last news will be recorded. Clinical data collected: patients and disease characteristics at the time of the diagnosis, disease and mutational status, cardio-vascular risk factors, history of thrombosis and cancer. Biological data collected: hemogram and bone marrow results if available. During the follow-up new data will be noted: treatment changes (reasons of change and type of drug), thrombotic events (localization, date and hemogram), phenotypic evolutions (type and date), death (date and etiology).</detailed_description>
	<mesh_term>Primary Myelofibrosis</mesh_term>
	<mesh_term>Polycythemia</mesh_term>
	<mesh_term>Polycythemia Vera</mesh_term>
	<mesh_term>Thrombocytosis</mesh_term>
	<mesh_term>Thrombocythemia, Essential</mesh_term>
	<criteria>Patients with ET or PV or PMF Signature of the nonopposition consent form</criteria>
	<gender>All</gender>
	<minimum_age>N/A</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>September 2016</verification_date>
</DOC>